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Homomers with ligand binding sites
involving multiple protein chains (MBS
homomers) evolve new functions slower
than other homomers and monomers,
and the ones binding cofactors/metals
also have more conserved quaternary
structure (QS). These complexes are
likely to be promising targets for
antibiotics and multitarget drugs.
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It has been suggested that the evolution of protein
complexes is significantly influenced by stochastic,
non-adaptive processes. Using ligand binding as
a proxy of function, we show that the structure of
ligand-binding sites significantly influences the evo-
lution of protein complexes. We show that homo-
mers with multi-chain binding sites (MBSs) evolve
new functions slower thanmonomers or other homo-
mers, and those binding cofactors and metals have
more conserved quaternary structure than other ho-
momers. Moreover, the ligands and ligand-binding
pockets of homologous MBS homomers are more
similar than monomers and other homomers. Our
results suggest strong evolutionary selection for
quaternary structure in cofactor-binding MBS homo-
mers, whereas neutral processes aremore important
in complexes with single-chain binding sites. They
also have pharmacological implications, suggesting
that complexes with single-chain binding sites are
better targets for selective drugs, whereas MBS ho-
momers are good candidates for broad-spectrum
antibiotic and multitarget drug design.
INTRODUCTION
The majority of genomic traits show dramatic changes with
organismal complexity and genome size (Lynch, 2007). Due to
their high effective population size, prokaryotes are character-
ized by small, dense genomes, where the amount of coding
sequence typically takes up more than 90% of the genome. In
contrast, in higher eukaryotes, the fraction of coding sequence
takes up only a small fraction (1%–2%) of the genome, and its
fraction changes gradually with genome size. A similar trend is
present for many other traits: intron size, intron number, number
of genomic parasites, codon bias, and recombination rate all
show clear correlations with the size of the genome (Lynch and
Conery, 2003), which is caused by the very different effective
population sizes and, in consequence, strength of selection in
species with large and small genomes (see Lynch, 2007 for an
overview).Cell R
This is an open access article undThere is, however, a notable exception to this pattern: protein
complexes. The majority of proteins do not function in isolation
but form complexes, which can be either homomeric, i.e., are
formed by several units of the same protein, or heteromeric,
which are formed by several different proteins (see recent re-
views by Levy and Teichmann, 2013 and Marsh and Teichmann,
2015). Whereas it is known that, during crystallization, non-phys-
iological complexes are formed frequently, an implicit assump-
tion of most studies on complex evolution is that the structure
of protein complexes is adaptive and is a result of selection
(Ali and Imperiali, 2005; Marianayagam et al., 2004; Nishi et al.,
2013). This assumption is highly intuitive and is supported by
numerous observations. For example, pathogenic mutations
are highly enriched in protein interfaces (Sahni et al., 2015;
Yates and Sternberg, 2013), quaternary structure is frequently
conserved (Levy et al., 2008), protein complex assembly path-
ways tend to be evolutionarily optimized and conserved (Marsh
et al., 2013; Wells et al., 2016), and different biological functions
are strongly associated with different types of quaternary struc-
ture (Bergendahl and Marsh, 2017). However, Lynch (2013) has
recently pointed out that, unlike most genomic traits, the fre-
quency of protein complexes in different taxa, and their quater-
nary structure, do not show the same dramatic changes with
the complexity of organisms (and in consequence, their effective
population size) as most genomic traits and thus do not scale
with the strength of selection. This suggests that stochastic
processes may play a fundamental role in the evolution of com-
plexes, particularly in the case of homomers (Lynch, 2013).
Further support for this hypothesis comes from the observation
that the global distribution of quaternary structure topologies in
complexes with experimentally determined structures is largely
consistent with the distribution expected from random combina-
tions of evolutionary steps (Ahnert et al., 2015).
In this paper, using ligand binding characteristics of proteins
present in the PDB, we test whether the acquisition of novel
functions/ligands depends on protein quaternary structure and
whether it depends on the structure of the ligand binding pocket.
We hypothesized that changes in the assembly and organization
of protein complexes can result in a rapid emergence of novel
functions without dramatic changes in the tertiary structure if
the functional sites are formed by more than one protein in the
complex (thus changes in assembly might be a source of evolu-
tionary innovations). Whereas protein-ligand interactions have
been studied for decades and are of fundamental importanceeports 22, 3265–3276, March 20, 2018 ª 2018 The Author(s). 3265
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
in drug discovery (where it is generally assumed that similar
binding sites bind similar ligands; Klabunde, 2007), large, PDB-
scale analyses of protein-ligand interactions have so far charac-
terized such interactions only at a protein domain or fold level
(Furnham et al., 2016; Ji et al., 2007; Kinjo and Nakamura,
2009; Nath et al., 2014), and we are not aware of any study
that tested whether there are general relationships between
complex formation, complex evolution, and ligand binding. We
find that the structure of the ligand binding pocket has a pro-
found influence on the evolution of protein function. In the
case of complexes where the residues of a binding site are
restricted to a single protein chain, the characteristics of ligand
binding in protein complexes and monomers do not differ qual-
itatively, suggesting that, in the case of these complexes, the
‘‘Lynch conjecture’’ is likely to be correct and neutral processes
are very important in the evolution of quaternary structure of
such complexes. In contrast, in homomers with small-molecule
binding sites involving residues from several protein chains, we
observe clear differences that contradict our initial hypothesis:
they acquire novel ligands/functions much slower than mono-
mers and bind chemically more similar ligands. In addition, in
the case of homomers with multi-chain binding metals or cofac-
tors, we observe a markedly lower variability in quaternary struc-
ture (unit number) than in homomers with single-chain binding
sites (SBSs). We also find that the ligands of homomers
with multi-chain binding sites (MBSs) show significantly lower
structural variability than monomers or other homomers, are
significantly enriched in nucleobase-containing ligands, and
frequently perform metabolic functions.
RESULTS
The Structure of Ligand Binding Site Influences the
Evolution of Function of Complexes
We use ligand binding and the presence of binding pockets as a
proxy of protein function because it allows comparisons on a
PDB-wide scale and is based on experimental data; thus, one
can compare homologs without the assumption of functional
similarity. To test whether the evolution of protein function is
significantly influenced by quaternary structure, we used the
BioLiP database (Yang et al., 2013), a semi-manually curated
database of protein-ligand interactions. BioLiP contains only li-
gands that are likely to be biologically relevant (and thus are
not artifacts of crystallization, such as solvents used in structure
determination) and also provides an annotation of the ligand
binding residues. We classified homomer and heteromer binding
sites into two groups: sites where the binding residues are
located on only one chain of the complex (SBSs) and sites where
the binding residues of a particular ligand are located on more
than one chain (MBSs; Figures 1A and 1B). We grouped ligands
into three categories: cofactors; metals and small molecules;
and excluded nucleic acids and peptide ligands from the anal-
ysis. The distribution of the three ligand types is not identical in
the five protein groups. Whereas small molecules dominate the
ligands in all groups, MBS complexes are characterized with a
higher frequency of cofactors and fewer metals (Figure 1C) and
have somewhat fewer ligands per protein than SBS complexes
and monomers (Figure 1D).3266 Cell Reports 22, 3265–3276, March 20, 2018We examined the evolution of protein function by testing how
the ability of binding the ligands of homologous structures
changes with their sequence similarity. We used ProBiS (Konc
and Janezic, 2010, 2017) to search for the presence of ligand
binding sites in homologous proteins (Experimental Procedures
and Figure 1E) and ordered the frequency of different binding
sites (i.e., the frequency of sites not having a significant hit in a
homolog) according to the sequence similarity of homologous
sequence pairs (Figure 2). The comparison of homomers and
heteromerswithmonomers indicates that the binding sites of ho-
momers with MBSs are much more likely to be found in homo-
logs than in SBSs or monomers (Figures 2A and 2B), particularly
in the case of distant homologs. In contrast, heteromers with
multi-chain binding pockets do not show the same pattern (Fig-
ures 2C and 2D).
The higher conservation of MBSs of homomers (Figure 2A) is
caused by two independent processes: the significantly slower
divergence of small-molecule binding pockets and the some-
what different frequencies of cofactors and metals in this protein
group. The three ligand categories show different evolutionary
patterns: the binding pockets of small molecules show much
higher conservation in MBS homomers than in monomers or
SBS homomers (Figures 2E and 2F), whereas, in case of hetero-
mers, their binding sites appear to diverge faster than in mono-
mers (Figures S1A and S1B). The binding pockets of cofactors
are much more conserved: almost no differences are present
above 40% sequence similarity (Figures 2G, 2H, S1C, and
S1D), which is caused by their ancient evolutionary origins,
possibly dating back to the RNA world (reviewed in Smith and
Morowitz, 2016) but also by the very low structural diversity of
this group, i.e., the fact that many distantly related homologs
share the same cofactor. In contrast, the binding pockets of
metal ions are the less conserved and show no clear differences
between the five protein groups (Figures 2I, 2J, S1E, and S1F),
which may be partly caused by the small size of these pockets,
resulting in lower efficiency of detection in homologous proteins.
Cofactors and Metals Binding Multiple Protein Chains
Influence the Evolution of Quaternary Structure
Next, we tested whether the observed differences in binding
result in differences in the variability of quaternary structure, as
defined by the number of subunits in a complex. We found
that, in the case of proteins with MBS cofactors or metals, qua-
ternary structure evolves differently in MBS and SBS complexes
(Figures 2K, 2L, S2E, and S2F), but surprisingly, in MBS com-
plexes binding only small molecules, there is no such effect
(Figures S2K and S2L). In homomers with codactors/metals,
MBS complexes show a much higher conservation of unit
number than in SBS complexes (Figures 2K and S2), whereas
in heteromers, the pattern is the opposite: the structure of
suchMBS heteromers appear to change faster than SBS hetero-
mers (Figures 2L and S2F). Besides contributing to catalysis
(Fischer et al., 2010), certain cofactors and metals are known
to stabilize the tertiary structure of proteins; classic examples
include the heme of myoglobin and cytochrome-c. Our results
strongly suggest that MBS cofactors and metals also influence
the formation and evolution of protein complexes. InMBS homo-





Figure 1. Examples of SBSs and MBSs in
Homomers and Ligand Distributions
(A) Human ketohexokinase complexed with pyr-
imidopyrimidine (PDB ID: 3Q92). The protein forms
a dimer, and each subunit has an independent
binding pocket, containing a ligand (red). Residues
binding the ligand are highlighted in yellow.
(B) Anemone STING (stimulator of interferon [IFN]
genes) protein, complexed with cyclic diguano-
sine monophosphate (PDB ID: 5CFL). The homo-
dimer has only one binding site, which is formed
by both protein chains. Residues binding the
ligand are highlighted in yellow.
(C) The composition of biologically relevant li-
gands in monomers, SBS homomers, MBS ho-
momers, SBS heteromers, and MBS heteromers.
In all cases, the majority of ligands are small
organic molecules, but MBS complexes are
characterized with higher fraction of cofactors and
fewer metal ions. Nucleic acids and peptides were
not used in the analyses.
(D) Boxplots of the number of ligands in the
five protein categories, excluding outlayers. The
number of different ligands per protein follows an
exponential-like distribution, with the majority of
proteins having one or two different ligands.
(E) Outline of the ligand binding pocket searches:
for each pair of homologous proteins, we per-
formed an exhaustive search, i.e., we searched all
structures of the target protein with all ligand
binding pockets of all structures of the query
protein, using both proteins as target and query.evolution of quaternary structure, and selection is likely to influ-
ence the assembly and composition of such homomers more
than of SBS homomers. In contrast, in MBS heteromers, they
seem to contribute to evolutionary innovations (Figure 2L).
In the case of complexes without cofactors or metals, the evo-
lution of quaternary structure does not seem to evolve differently
in SBS andMBS complexes, despite the clear differences in their
ligand binding patterns (Figures S2G–S2L). However, in the case
of such heteromers, the lack of increasing trend with sequence
divergence (i.e., the fact the more distant sequences do not
have more different quaternary structure; Figure S2L) suggest
that, besides biological factors, the observed patterns are
also significantly influenced by biases in the PDB. This could
be caused by incomplete crystals or the recent availability ofCell Repcryoelectron microscopy (cryoEM) struc-
tures, which are typically much larger
than the structures obtained with X-ray
crystallography.
Complexes with MBSs Have
Chemically Less Variable Ligands
and Binding Sites
What mechanism could be responsible
for the slower functional change seen
in MBS homomers? There are two funda-
mentally different possibilities. First,
MBSs may be more generic and flexible,and in consequence, they may be able to process a broader
spectrum of ligands. Examples of this are certainmembrane pro-
teins, receptors, and regulatory proteins (Pabon and Camacho,
2017). It has been shown recently that, in the case of a multidrug
resistance protein, the conformational variability of its bipartite
binding site is the most likely cause of its very broad substrate
specificity (Johnson and Chen, 2017). However, flexible binding
sites and broad substrate specificity are also present in some
SBS homomers (Hvorecny et al., 2017) and even monomers
(Fong et al., 2017). Alternatively, the functions and ligands
of MBS homomers may be more conserved than of SBS
homomers.
We tested which of these hypotheses is true by comparing





Figure 2. Evolution of Ligand Binding and QS
We use the ability to bind ligands of homologous proteins (scaled with sequence similarity) as the measure of their functional similarity.
(1) General relationships between ligand binding and QS in homomers, heteromers, and monomers.
(A) Homomers with MBSs show amuch slower functional divergence than monomers. This pattern is caused by two separate processes: (1) the binding pockets
of small-molecule ligands diverge significantly less rapidly than the pockets of monomers and (2) MBS homomers have a higher fraction of cofactors, which are
frequently identical and have highly conserved binding pockets plus fewer metal ions.
(B) In homomers with binding sites restricted to a single chain, the ability to bind the ligands of homologs changes qualitatively similarly to monomers.
(C) MBS heteromers do not show the same pattern as MBS homomers.
(legend continued on next page)
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variability of the binding sites. We tested the chemical similarity
of ligands of homologous structures using the ChEBI (Chemical
Entities of Biological Interest) ontology database (Degtyarenko
et al., 2008; Hastings et al., 2016). ChEBI provides a manually
curated hierarchical ontology, conceptually similar to gene
ontology (GO), that is based on chemical structure (Figure 3A).
We used the number of different terms between chemical com-
pounds in the ontology to quantify the chemical and structural
difference between organic ligands, excluding nucleic acids,
and peptides (Figure 3A). Our analysis shows that, in the
case of MBS homomers, the difference between ligands of ho-
mologs is smaller than between ligands of monomers, whereas
in the case of SBS complexes, the difference is somewhat
larger or not significant (Figures 3B–3E). Excluding cofactors
from the analyzed ligands does not change the pattern dramat-
ically (Figure S3), although it does influence the most diverged
homologs.
Ligand binding frequently results in conformational changes
of proteins, and we also tested the structural variability of the
binding site by comparing the root mean square deviation
(RMSD) of the significant hits (with Z score > 2) of homologs
with sequence similarity between 30% and 49%. Because
RMSD depends on the size of the superposed structures,
we used the size of the matching pocket as a covariate. We
expected that hits to binding sites in proteins with more
different ligands and binding sites will have higher RMSD. As
predicted, we found a significant difference between MBS
and SBS homomers (Figure 4A), but we found no consistent
difference in heteromers (Figure 4B), irrespectively whether
cofactors were included or excluded from the dataset. Addi-
tionally, using those proteins where ligand binding (holo) and
ligand-free (apo) structures are both present in the PDB, we
tested whether ligand binding results in a larger conforma-
tional change in MBS homomers than SBS homomers
(measured as the RMSD of the ligand binding pocket of the
holo structure in the apo structure). We did not find a clear dif-
ference between the two (Figure 4D). Our results based on
pocket comparison support the findings based on chemical
similarity: on average, the structural variability of the binding
sites in MBS homomers is lower than of SBS homomers,
and the cases where flexibility is assumed to result in ligand
promiscuity are most likely a minority.(D) In SBS heteromers, similarly to SBS homomers, the ability to bind the ligands
complexes, stochastic processes (i.e., drift) are likely to play a significant role in
(2) Evolution of ligand binding of different ligand categories in homomers (see Fig
(E and F) The binding pockets of small molecules show much higher conservatio
(G and H) In the case of cofactors, the binding pockets are highly conserved
homomers).
(I and J) The metal binding pockets are the less conserved and show no qualitat
homomers; SBS homomers).
(3) Evolution of quaternary structure.
(K) In homomers that bind cofactors or metal ions, the structure of binding pockets
also Figure S2). Homomers withmulti-chain biding sites have significantly lower va
structure of the binding pocket is an important determinant of the evolution of th
(L) In the case of heteromers with cofactors andmetals, we see the opposite patter
than SBS heteromers.
On all panels, bars represent proportions, whiskers 95% confidence intervals. **p
multiple testing.The PDB is not an unbiased database, as its composition is
significantly influenced by the priorities of the research com-
munity. Thus, the observed differences could also be caused
by biases in the PDB rather than real biological differences,
if MBS homomers have consistently more homologs in the
PDB having identical ligands or have been systematically crys-
tallized with fewer ligands. To rule this out, we determined the
ligand diversity of sequences in the PDB, measured as the to-
tal number of ligands of the homologs of a sequence divided
by the number of homologs it has (Figure S4). Note that,
because we ignored structural differences between ligands,
high diversity does not necessarily mean high structural vari-
ability (for example ATP and ADP are different ligands,
although are structurally very similar) but simply the high num-
ber of non-identical compounds, irrespectively whether they
are small modifications of each other or radically different;
thus, this measures research effort and not structural vari-
ability. The results show that proteins with MBSs have higher
number of ligands per sequence, indicating that the higher
similarity of ligands and lower structural variability of MBS ho-
momers are not caused by their lower ligand diversity in the
PDB (Figure S4).
Functional Analysis of MBS Homomers
To test whether MBS homomers have characteristic func-
tions, we performed a Gene Ontology enrichment analysis
and also an enrichment analysis of the ChEBI terms of their
ligands. We found that, whereas the molecular functions of
MBS homomers are diverse, several functions are signifi-
cantly enriched in comparison to all ligand binding homo-
mers, including acyl-coenzyme A (CoA) dehydrogenase activ-
ity, transaminase activity, thiamine pyrophosphate binding,
cofactor binding, transmembrane transport, ion binding,
transporter activity, and other functions frequently involving
cofactor binding (Figures 5A and S5; Table S1). Next, we
tested whether the chemical composition of the ligands of
MBS homomers is biased toward certain chemical groups
by a ChEBI structural term enrichment analysis (Experimental
Procedures). We found that the ligands that are present in
ChEBI (of the almost 20,000 ligands present in BioLiP at the
time of writing, only 3,100 are present in ChEBI) show clear
structural biases: the most enriched chemical structures areof homologs changes qualitatively similarly to monomers. In the case of SBS
shaping the number of subunits or their topology.
ure S1 for heteromers).
n in (E) MBS homomers than in monomers or (F) SBS homomers.
and show little difference between QS types (G, MBS homomers; H, SBS
ive differences between the groups, most likely due to their small size (I, MBS
have fundamental consequences for the evolution of quaternary structure (see
riability in quaternary structure than complexes with SBSs, suggesting that the
eir quaternary structure.
n to homomers in the evolution of QS:MBS heteromers appear to change faster
< 0.005; *p < 0.05; tests of proportions, with Benjamini-Hochberg correction for




Figure 3. Homomers with MBSs Are Charac-
terizedwith ChemicallyMore Similar Ligands
(A) Example of ChEBI ontology similarity between
two different chemical compounds (dopamine and
guanine). Shared ontology terms are highlighted
with red; dopamine and guanine specific terms are
highlighted with blue and green, respectively.
The difference in their chemical composition was
measured as the proportion of the ligand specific
and all terms, i.e., (blue + green)/all terms: (15 + 17)/
49 = 65%.
(B and C) The chemical properties of ligands
of homomers with MBSs (B) change less with
sequence divergence than the properties of ligands
of monomers or other complexes, but not in het-
eromers (C).
(D and E) Ligands of homomers with SBSs (D) show
a weak but consistently higher variability in the
chemical properties of ligands than monomers,
while there is no clear difference between SBS
heteromers (E) and monomers.
Bars represent averages; whiskers 95%confidence
intervals; **p < 0.005; *p < 0.05; t tests, with Ben-
jamini-Hochberg correction for multiple testing.
See also Figure S3.nucleobase-containing ligands, frequently containing ribonu-
cleotides (Figure 5B; Table S2). It has been long known that
many protein cofactors are derivatives of nucleotides (Petsko
and Ringe, 2008), and it has been suggested that this pattern
is ancient and might have originated in the RNA world (Ji
et al., 2007; White, 1976). However, excluding cofactors
from the analyzed ligands does not change the pattern qual-
itatively. To assess the biochemical role of these ligands, we
also performed an enrichment analysis of the ChEBI role
ontology terms, which indicates that the most significantly en-
riched terms are metabolites, including fundamental metabo-
lites (Figure 5C; Table S3), irrespectively whether cofactors
are included or not. This suggests that MBS homomers are3270 Cell Reports 22, 3265–3276, March 20, 2018performing central, mostly metabolic,
and probably ancient functions.
General Evolutionary and Structural
Characteristics of Complexes with
Single- and Multi-chain Binding
Complexes
The patterns described above could also
potentially emerge if MBS homomers are
significantly younger and faster evolving
than SBS monomers or homomers, which
could result in the observed lower chemi-
cal variability, as younger protein families
are expected to have less diverse func-
tions (Osadchy and Kolodny, 2011). To
test this, we compared the age of proteins
that are part of MBS and SBS complexes,
using the human protein age dataset pro-
vided by Capra et al. (2012, 2013; Exper-
imental Procedures). We found no signifi-cant difference in the ages of MBS and SBS complexes
(Figure S6). In fact, MBS complexes are somewhat more en-
riched in the oldest age groups, which is in agreement with
the higher frequency of cofactor binding in these groups
(Figure 1).
Ligand binding frequently results in conformational changes
of both proteins and their ligands (Stockwell and Thornton,
2006), and flexibility has been shown to be essential for the
proper functioning of ligand-binding proteins (Petsko and
Ringe, 2008). Therefore, because differences in flexibility
could have significant consequences for ligand binding, we
compared the flexibilities of subunits from MBS and SBS com-
plexes using a simple method based upon relative solvent
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Figure 4. Homologs of MBS Homomers
Have More Similar Binding Site Structure
Than SBS Homomers or Monomers
(A–C) The comparison of binding sites of homol-
ogous proteins with 30%–50% sequence identity
indicates that the structural variability of binding
sites of (A) homomers (measured as the root mean
square deviation [RMSD], in angstrom) with multi-
chain binding pockets is significantly lower than
the variability of single-chain binding pockets,
whereas there is no such pattern in heteromers (B).
Monomers (C) show a pattern comparable to SBS
homomers.
(D) The comparison of apo and holo structures of
homomers indicates that the binding pockets
MBS homomers do not show a larger structural
variability than SBS homomers.
**p < 0.005; *p < 0.05; Wilcoxon tests with Benja-
mini-Hochberg correction.accessible surface area (Arel). Essentially, Arel is the ratio of the
solvent accessible surface area observed for a polypeptide
chain (ignoring intermolecular interactions) to the value ex-
pected for a folded protein of the same molecular weight
(Marsh and Teichmann, 2011). Previously, Arel parameter has
been shown to correlate very well with several more complex
measures of protein flexibility as well as the magnitude of
conformational changes that occur upon binding. Thus, it pro-
vides a simple way to analyze the flexibilities of protein com-
plex subunits on a large scale. Interestingly, we observe that
MBS complexes are generally more flexible than SBS com-
plexes (Figure 6A). Previously, it was demonstrated that the
subunits of protein complexes, heteromers in particular, are
more flexible in their unbound states than monomers (Marsh
and Teichmann, 2014) and that subunits of complexes with
different symmetry types have different flexibilities (Marsh and
Teichmann, 2014), i.e., cyclic homomers are more flexible
than dihedral homomers. A comparison of symmetry types of
homomers nevertheless indicates that the higher flexibility of
MBS homomers is not a byproduct of biases in symmetry:
MBS homomers are not consistently enriched among com-
plexes with cyclic symmetry (Figure 6B). The biological function
of the higher flexibility of MBS complexes is unclear; one
possibility is that it is the consequence of the somewhat larger
ligands of MBS complexes, which may require larger confor-
mational changes upon binding.
Prokaryotes and eukaryotes are characterized with different
frequencies of homomers and heteromers, with homomers be-
ing much more frequent in prokaryotes (Lynch, 2012; Marsh
et al., 2015; Figure 6C). We hypothesized that, due to much
stronger selection in prokaryotes, complexes where the topol-
ogy is more influenced by stochastic processes, i.e., SBS com-Cell Repplexes, will have a lower frequency in
prokaryotes. Our results show that the
frequency of SBS complexes is indeed
significantly (although not dramatically)
lower in prokaryotes than in eukaryotes
both in the case of homomers and hetero-mers (Figure 5D), supporting the hypothesis that SBS complexes
are subject to weaker selective constraints.
Pathogenic Mutations Are Most Enriched in the Binding
Sites of Heteromers
Finally, we tested whether quaternary structure and the structure
of binding pockets influences the pathogenicity of mutations in
the binding sites. Proteins with different quaternary structure
have different baseline levels of pathogenic mutations, which in-
crease from monomers through homomers to heteromers, with
MBS complexes having higher frequencies of pathogenic muta-
tions than SBS complexes, both in homomers and heteromers
(Figure 7; baseline is indicated with a red horizontal line). Muta-
tions in binding sites are known to be more pathogenic than
other mutations, and our findings confirm this; in most complex
types, the frequency of pathogenic mutations is significantly
higher than the baseline level (*p < 0.05; **p < 0.005; tests of pro-
portions). The highest frequencies of pathogenic mutations are
in the binding sites of heteromers (Figure 7B), which in the
case of small-molecule binding MBS heteromers, is close to
30% of mutations. In the case of metal-binding MBS homomers,
the total number of pathogenic mutations is very low, altogether
5, which results in low statistical power (Table S4).
DISCUSSION
Our findings indicate that the structure of ligand binding site, i.e.,
whether it is formed by residues of a single chain or by multiple
chains, has profound consequences for the evolution of protein
function and, in the case of cofactor or metal-binding proteins,
also for quaternary structure. In the case of SBS complexes,
the change in ligand binding follows qualitatively the sameorts 22, 3265–3276, March 20, 2018 3271
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Figure 5. Functional Characteristics of MBS Homomers, in Relation to All Homomers included in the Analysis
(A) Scatterplot of significantly enriched GOmolecular function terms, summarized and visualized with REVIGO. Related terms form clusters that are labeled with
the most significant term of the cluster. The size of the circles corresponds to the number of proteins in the term; colors indicate significance. (See also Figure S5
and Table S1 for all enriched terms and exact significances.) MBS homomers have diverse functions, including acyl-CoA dehydrogenase activity, transaminase
activity, thiamine pyrophosphate binding, cofactor binding, transmembrane transport, ion binding, or transporter activity, which frequently involve binding of
cofactors.
(B) Graph of significantly enriched ChEBI structural ontology terms. White nodes are not significant; the intensity of red corresponds to significance (see Table S2
for exact p values). Most enriched structural terms are related to nucleobases/nucleotides.
(C) Graph of significantly enriched ChEBI role ontology terms. (See Table S3 for exact p values.) The enrichment shows that the ligands of MBS homomers are
typically involved in metabolism.pattern as in monomers, indicating that, in the case of such com-
plexes, ligand binding is influenced little by quaternary structure
and the evolution of quaternary structure is likely to be more
influenced by stochastic processes, as it was suggested by
Lynch (2013; Figure 2). Additionally, among all complex types,
the baseline frequency of pathogenic mutations is the lowest in3272 Cell Reports 22, 3265–3276, March 20, 2018SBS complexes (Figure 7), further supporting this hypothesis.
In contrast, in complexes that bind metals and cofactors, the
quaternary structure of both MBS homomers and MBS hetero-
mers evolves at a significantly different rate than in SBS com-
plexes. Surprisingly, we found no evidence that changes in qua-



































































































Figure 6. Structural and Evolutionary Char-
acteristics of Single- and Multi-chain Bind-
ing Complexes
(A) Subunits forming MBSs are significantly more
flexible than subunits with single-chain sites
(Wilcoxon tests).
(B) The frequency of single- andmulti-chain binding
sites in different symmetry groups of homomers.
The symmetry groups are A, asymmetric; C, cyclic;
C2, two-fold dimeric; C2h, two-fold symmetric with
>2 subunits; and D, dihedral (tests of proportions).
(C) The frequency of homomers is higher among
prokaryotes, whereas heteromers are more
frequent in eukaryotes (tests of proportions).
(D) The frequency of complexes with MBSs is
higher in prokaryotes than in eukaryotes, particu-
larly in the case of heteromers (tests of proportions).
On (B)–(D), whiskers represent 95% confidence
intervals. On all panels, **p < 0.005 and *p < 0.05.homomers (at least when considering ligand binding): both
ligand binding and the ligands of MBS homomers change signif-
icantly less with sequence evolution than in monomers (Figures
2A and 3A). The higher variability of quaternary structure (i.e.,
unit number) in cofactor-binding SBS homomers (Figure 2K)
also suggests that purifying selection is more important in
shaping the quaternary structure of MBS homomers than of
SBS homomers.
In the case of cofactor-binding heteromers, we see the oppo-
site pattern: the unit number of MBS complexes changes faster
than the unit number of SBS complexes, indicating that, in such
complexes, changes in complex topology are a source of evolu-
tionary innovations (Figures 2L and S2). However, for heteromers
that do not bind cofactors or metals (Figure S2), it is currently
unclear to what degree the observed patterns are caused by
real changes in function or the incompleteness of heteromeric
structures in the PDB, and they probably require additional,
more complete structures and more fine-grained analyses to
be able to reach a conclusion.
The finding that the evolution and assembly of SBS complexes
may be significantly influenced by non-adaptive processes does
not mean that it is entirely stochastic—we observe a significantly
higher baseline level of pathogenic mutation in SBS homomersCell Repthan monomers (Figure 7), and the qua-
ternary structure of such homomers is still
frequently conserved (Levy et al., 2008;
see also Figures 2 and S2). How-
ever, in addition to adaptive forces, the
nonlinear change of tertiary structure
with sequence similarity may contribute
to the pattern. Typically, above 40%
sequence identity, the tertiary structure
of homologous proteins differs little (see
Abrusán and Marsh, 2016 for examples),
and structural similarity declines signifi-
cantly only below 30% sequence iden-
tity. In fact, structure is so much more
conserved than sequence that homol-ogy-based tools for tertiary structure prediction like Rosetta
(Kim et al., 2004) or I-TASSER (Yang et al., 2015) can frequently
build reliable predictions based on templates with as low as
15% sequence identity. Thus, similar quaternary structure of
homologs might be, to some degree, the byproduct of their
similar tertiary structure: similar building blocks result in similar
complexes.
The observation that ligand structure and ligand pocket struc-
ture changes much less with sequence in MBS than SBS homo-
mers is likely to have important consequences for drug design:
the development of broad-spectrum antibiotics and antiviral
drugs; for polypharmacology (Bolognesi and Cavalli, 2016);
and also drug repositioning. Our findings suggest that antibiotics
targeting MBS homomers are likely to be broader spectrum than
antibiotics that target SBS homomers. In addition, it is likely that
evolving resistance to drugs that target MBS homomers is more
difficult, at least where the evolution of resistance is due to the
accumulation of mutations, like in rapidly evolving retroviruses.
The traditional aim of drug design has been designing drugs
that bind specifically to one target protein (monopharmacology)
to achieve maximum specificity and minimize side effects.
However, it has become clear that many diseases, like cancers
and psychiatric diseases, have polygenic causes, and in suchorts 22, 3265–3276, March 20, 2018 3273
Figure 7. The Frequency of Pathogenic
Mutations Is Different in Different Com-
plexes
(A–D) Complexes with (A) small molecules, (B)
cofactors, (C) metal ions, and (D) all ligands.
The baseline level of pathogenic mutations is
highest in MBS heteromers and lowest in
monomers. In most complex types, the fre-
quency of pathogenic mutations of the binding
sites is higher than the baseline level, particu-
larly in the case of heteromers. **p < 0.005; *p <
0.05; tests of proportions; whiskers represent
95% confidence intervals.diseases, drugs that target several proteins simultaneously
(multi-target or promiscuous drugs) can be much more efficient
than single-target drugs, despite their more complex and less
understood pharmacology (Peters, 2013; Roth et al., 2004).
Because similar binding pockets in general bind similar ligands
(Klabunde, 2007), protein families with many MBS homomers
are likely to be good candidates for the development of multi-
target drugs, particularly in cancers, due to the specific meta-
bolic characteristics of many cancers (Cairns et al., 2011).
Finally, our results may be also relevant for drug repositioning
(Li and Jones, 2012), because binding site similarity is a require-
ment for repositioned drugs. An example is the retroviral drug
nelfinavir, which binds HIV protease, a homomer with a MBS,
and is currently being repositioned as a (promiscuous) cancer
drug (Koltai, 2015).EXPERIMENTAL PROCEDURES
Data Sources and Data Preprocessing
The sequences of proteins having a structure in the PDB were downloaded
from Uniprot, and we used the Uniprot mappings between sequences and
PDB structures. To identify homologous protein pairs, we performed an all
versus all BLAST search on these sequences, with an e-value cutoff 104;
the sequence pairs with significant BLAST hits were realigned with Muscle
(Edgar, 2004), and their global sequence similarity was determined. Chimeric
sequences were excluded from further analyses, and the sequences were
clustered at 100% sequence similarity to remove redundancies. For every pro-
tein sequence, we determined the PDB entries associated with it and filtered
out the PDB entries that are part of a virus, form protein fibrils, are helical, or
contain sequences from more than one species (this also removes most pep-
tide-binding antibodies). The quaternary structure of the proteins was deter-
mined using the biological units as follows: if a protein is part of at least one
heteromer PDB structure, it was classified as a heteromer; else, if it has at least
one homomeric PDB entry, it was classified as a homomer, and the remaining
sequences were classified as monomers. Heteromer PDB structures were
defined as structures with chains from minimum two different proteins,
irrespectively of the length of the chains.3274 Cell Reports 22, 3265–3276, March 20, 2018We used the BioLiP database (Yang et al., 2013)
of protein-ligand interactions to determine ligand
binding residues and whether a ligand is bound
to several protein chains or a single one. BioLiP
is a semi-manually curated database, which con-
tains only ligands that are assumed to be biologi-
cally relevant and are not byproducts of the
crystallization procedure or other structure-deter-
mination methods. It contains all structures from
the PDB with a biologically relevant ligand (at thetime of writing 71,925 structures, after excluding structures binding only nu-
cleic acids and peptides), but it is based on the asymmetric units. Because
in the analyses, we used the biological units of PDB entries (the functional
form of the structures), we excluded all entries, altogether 13,413, where the
asymmetric unit and biounit is different and the number of proteins is larger
in the biounit than in the asymmetric unit, as the ligand annotation of these
entries is incomplete in BioLiP. In the case of entries where the asymmetric
units contain the biounit, differences between the two are incorporated into
the BioLiP annotation; see Yang et al. (2013) for details.
From the ligands of BioLiP, we used cofactors, metal ions, and small mole-
cules. Cofactors were determined as ligands that are annotated as cofactors in
the ChEBI database (Hastings et al., 2016) or in Fischer et al. (2010). Small mol-
ecules were defined as every ligand that is not a cofactor, metal ion, nucleic
acid, or a peptide.Searches for Ligand Binding Sites
We used ProBiS (Konc and Janezic, 2010, 2017) to identify ligand binding
pockets in homologous proteins, which identifies binding sites by local
structural search and compositional similarity. We performed all versus all
searches between homologous protein pairs; i.e., we searched all structures
of the target protein with all ligands of all structures of the query protein (Fig-
ure 1E). In the first step, the biological units of every PDB entry were prepro-
cessed: their atoms and chains were renumbered so that every atom and pro-
tein chain was unique in the structure, and from the target protein structures,
all ligands were removed, whereas from the query structures, only waters.
Due to the limitations of PDB format, structures with more than 99,999 atoms
were not included in the analyses. Next, the binding sites of ligands present in
BioLiP were extracted from the query structures, which were defined as the
surface residues within 3 Å of the ligand. For the target structures, the entire
surface of the protein (complex) was extracted, and the binding sites were
searched against the surfaces of the target proteins with ProBiS. For every
hit, the Z score, RMSD, e-value, and the size of the match were determined
(size was determined as the number of aligned vertices; see Konc and
Janezic, 2010 for details). We accepted a hit as significant if the Z score of
the match was equal or higher than 2 and its e-value was lower than 104.
The fraction of different binding sites for a pair of homologs was determined
as the number of ligands without a significant hit in the homolog divided by
the total number of ligands searched and was plotted against the sequence
similarity of the homologous proteins. In addition, we tested how efficient is
ProBiS in finding matches and whether there are systematic differences be-
tween homomers, heteromers, and monomers by determining the fraction
of significant hits between homologous structures that are known to bind
the same ligand (Figure S7). We found that the efficiency of ProBiS is high
and is not influenced qualitatively by the size or number of chains in a PDB
entry (Figure S7).
Determination of Ligand Chemical Similarity and Binding Site
Variability
We used the obo ontology files downloaded from the ChEBI database (Deg-
tyarenko et al., 2008; Hastings et al., 2016) to compare the chemical similarities
of ligands. For every ligand, its entire structural ontology graph was computed
from the obo files using a recursive algorithm, using the ‘‘is_a’’ tag, and the
average of the shared/different termswas determined for every possible ligand
pair of the homologous sequences.
Structural variability of the binding sites of homologs was performed using
the RMSD of the significant hits (Z score R 2), using the sequence pairs
with 50%–30% identity. We used the size of the match as a covariate because
RMSD is not a size-independent measure; it was measured as the number
of aligned ProBiS vertices. We performed similar searches between the
ligand binding (holo) structures and ligand-free (apo) structures of the same
proteins when they were both available in the PDB. In these searches, no
significance cutoff was used. Variability in the structure of the binding sites
was measured as the average RMSD of the best hits, using the size of the
match as covariate.
Gene Ontology and ChEBI Ontology Enrichment
From the UniProt-CrossRef annotation of proteins that are present in the PDB,
we extracted the list of GO terms associated with a particular protein. Next, for
every protein, we extracted the entire hierarchy of its GO terms, i.e., all parents
up to the highest level ‘‘molecular function’’ term, and determined the enrich-
ment of GO terms in MBS homomers with GeneMerge (Castillo-Davis and
Hartl, 2003), using all homomers in the PDB as the background set. Signifi-
cances were corrected for multiple testing with the Benjamini-Hochberg
method (a.k.a. false discovery rate [FDR]), and the list of significantly enriched
terms was submitted to the Revigo server (Supek et al., 2011) to remove re-
dundancies, summarize, and visualize the results.
ChEBI term enrichment was determined as follows. We determined the
nonredundant list of ligands in MBS homomers and in all homomers, contain-
ing only a single instance of every ligand. For every ligand, we identified its
parental terms using the ChEBI structural (‘‘is_a’’) and role (‘‘has_role’’) ontol-
ogies. The enrichment of terms was also calculated with GeneMerge, which is
a generic tool for term-enrichment analysis of ranked lists. Enriched terms
(after correction for multiple testing with FDR) were visualized with a method
conceptually similar to the graphical output of GOrilla (Eden et al., 2009),
with directed graphs and using color coding to indicate the significance of
the enrichment, the intensity of red indicating significance. Graphs were drawn
using GraphViz.
Evolutionary and Structural Characteristics of Complexes
The evolutionary age of human proteins was based on the ProteinHistorian
database (Capra et al., 2012), using the Princeton Protein Orthology (PPOD)/
PANTHERv7 dataset, generated with asymmetric Wagner parsimony. The
flexibility of subunits of proteins was determined as described in Marsh and
Teichmann (2014); the symmetry type of homomeric complexes is based on
the classification of PDB.
Estimation of the Frequency of Pathogenic Mutants
The list of disease-causing mutations was downloaded from Ensembl
(variation dataset) and was mapped to the PDB structures of human proteins
or their homologs if the sequence similarity between the human protein and its
homolog was higher than 90% and the mutated amino acid was identical. The
set of putative neutral mutations is based on ExAC variants (Lek et al., 2016)
that map to structures of the PDB using a similar procedure as described
above. The frequency of pathogenic mutants—both baseline and binding—
was determined for every protein type independently as the number of disease
mutations divided by the sum of disease and neutral mutations.Analysis Tools and Statistics
All analyses and statistical tests (except GO and ChEBI enrichment) were per-
formed with in-house Perl scripts and R. Protein structures were visualized
with UCSF Chimera (Pettersen et al., 2004).
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